FDA to increase scrutiny of herbal supplements

FDA Commissioner Mark McClellan plans to announce his agency's intention to step up scrutiny of the health effects of herbal supplements. He is expected to highlight several supplements the FDA wants to examine closely, including bitter orange, which is being marketed as a substitute for the now-banned ephedra as a weight-loss treatment.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care